Hua Medicine (Shanghai) Ltd.
HUMDFOTCHealthcare● Active
$0.41
$-0.02(-5.02%)
Market Cap$409270592
P/E Ratio—
52W High$0.5
52W Low$0.15
Hua Medicine (Shanghai) Ltd. (HUMDF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HUMDF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Dec 31, 2024EPS Actual
-$0.02
Revenue
$0.02B
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Dec 31, 2024
After Market Close
HUMDF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.01B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.01B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 20, 2026 | -$0.03 | — | — | — | $0.07B | — |
| ◌ Q3 FY2026 | Aug 20, 2026 | -$0.04 | — | — | — | $0.07B | — |
| ◌ Q1 FY2026 | Mar 25, 2026 | -$0.04 | — | — | — | $0.07B | — |
| ◌ Q1 FY2025 | Mar 26, 2025 | — | — | — | — | — | — |
| — Q4 FY2024 | Dec 31, 2024 | — | -$0.02 | — | $0.02B | — | — |
| — Q3 FY2024 | Aug 29, 2024 | — | -$0.02 | — | $0.01B | — | — |
| ◌ Q1 FY2024 | Mar 28, 2024 | $0.07 | — | — | — | $0.11B | — |
| — Q4 FY2023 | Dec 31, 2023 | — | -$0.02 | — | $0.00B | — | — |
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 20, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 25, 2026
EPS Actual
—
EPS Est.
-$0.04
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 31, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q3 FY2024
Aug 29, 2024
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2024
Mar 28, 2024
EPS Actual
—
EPS Est.
$0.07
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 31, 2023
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.51 | $0.51 | $0.51 | 1 |
| Q3 FY2027 | $0.51 | $0.51 | $0.51 | 1 |
| Q2 FY2027 | $0.51 | $0.51 | $0.51 | 1 |
| Q1 FY2027 | $0.33 | $0.33 | $0.33 | 1 |
| Q4 FY2026 | $0.33 | $0.33 | $0.33 | 1 |
| Q3 FY2026 | $-0.22 | $-0.22 | $-0.22 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.8B | $0.8B | $0.8B | 1 |
| Q3 FY2027 | $0.8B | $0.8B | $0.8B | 1 |
| Q2 FY2027 | $0.8B | $0.8B | $0.8B | 1 |
| Q1 FY2027 | $0.6B | $0.6B | $0.6B | 1 |
| Q4 FY2026 | $0.6B | $0.6B | $0.6B | 1 |
| Q3 FY2026 | $0.5B | $0.5B | $0.5B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2024 | Dec 31, 2024 | — | $0.15 | $0.15 | +0.00% |
| — Q3 FY2024 | Aug 29, 2024 | — | $0.20 | $0.20 | +0.00% |
| — Q4 FY2023 | Dec 31, 2023 | — | $0.45 | $0.20 | -54.93% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -126.6% | $0.45 | $0.20 | -54.93% |
| ▼ Q1 FY2023 | Mar 29, 2023 | -147.3% | $0.45 | $0.45 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.45 | $0.45 | +0.00% |
| ▲ Q2 FY2022 | Jun 30, 2022 | +48.1% | $0.45 | $0.45 | +0.00% |
Q4 FY2024+0.00%
Report Date
Dec 31, 2024
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$0.20
Price After
$0.20
Q4 FY2023-54.93%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$0.45
Price After
$0.20
Q2 FY2023-54.93%
Report Date
Jun 30, 2023
EPS Beat/Miss
-126.6%
Price Before
$0.45
Price After
$0.20
Q1 FY2023+0.00%
Report Date
Mar 29, 2023
EPS Beat/Miss
-147.3%
Price Before
$0.45
Price After
$0.45
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.45
Price After
$0.45
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
+48.1%
Price Before
$0.45
Price After
$0.45
Avg Beat Reaction+0.00%
Avg Miss Reaction-27.46%
Beat Rate1 / 7 quarters
Largest Move-54.93% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HUMDF ends December
Hua Medicine (Shanghai) Ltd. (HUMDF) most recently reported earnings on December 31, 2024 for Q4 FY2024, posting EPS of $-0.02 (in line with the analyst consensus of —). The next HUMDF earnings date is expected around September 1, 2026.
Each quarter, investors track HUMDF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HUMDF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HUMDF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HUMDF earnings · 4 questionsHua Medicine (Shanghai) Ltd.'s next earnings report is expected around September 1, 2026. HUMDF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HUMDF historically reports after market close (AMC).
HUMDF earnings datewhen is HUMDF earningsHUMDF next earnings datewhen does HUMDF report earningsHUMDF earnings calendar
▸ Source: FMP · Hua Medicine (Shanghai) Ltd. SEC filings · US GAAP · Hua Medicine (Shanghai) Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026